Artículos por temáticas

Therapeutic intervention at cellular quality control systems in Alzheimer's and Parkinson's diseases

Arduino DM, Esteves AR, Silva DF, Martins-Branco D, Santos D, Pimentel DF, Cardoso SM.

Curr Pharm Des. 2011;17(31):3446-59. doi: 10.2174/138161211798072481.

Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients

Keller C, Kadir A, Forsberg A, Porras O, Nordberg A.

J Alzheimers Dis. 2011;24(1):109-23. doi: 10.3233/JAD-2010-101290.

[Compensatory function of transthyretin in Alzheimer's disease]

Shwartsman AL, Sarantseva SV.

Tsitologiia. 2011;53(10):772-7.

Management of suspected Alzheimer's disease patients by specialist physicians at the first visit in Spain: First Consultation Study

Martínez Lozano MD, Guzmán Quilo C; Primeras Consultas Study Group.

Expert Rev Neurother. 2011 May;11(5):657-63. doi: 10.1586/ern.11.45.

[Neuromidin in mixed vascular and Alzheimer's dementia]

Damulin IV, Stepkina DA, Lokshina AB.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2):40-3.

Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor

May PC, Dean RA, Lowe SL, Martenyi F, Sheehan SM, Boggs LN, Monk SA, Mathes BM, Mergott DJ, Watson BM, Stout SL, Timm DE, Smith Labell E, Gonzales CR, Nakano M, Jhee SS, Yen M, Ereshefsky L, Lindstrom

J Neurosci. 2011 Nov 16;31(46):16507-16. doi: 10.1523/JNEUROSCI.3647-11.2011.

Influence of lithium treatment on GDNF serum and CSF concentrations in patients with early Alzheimer's disease

Straten G, Saur R, Laske C, Gasser T, Annas P, Basun H, Leyhe T.

Curr Alzheimer Res. 2011 Dec;8(8):853-9. doi: 10.2174/156720511798192754.

The radical scavenger IAC (bis(1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl) decantionate) decreases mortality, enhances cognitive functions in water maze and reduces amyloid plaque burden in hAβPP transgenic mice

Puoliväli J, Nurmi A, Miettinen TK, Soleti A, Riccardino F, Kalesnykas G, Heikkinen T, Vartiainen N, Pussinen R, Tähtivaara L, Lehtimäki K, Yrjänheikki J, Canistro D, Sapone A, Spisni E, Paolini M.

J Alzheimers Dis. 2011;27(3):499-510. doi: 10.3233/JAD-2011-110881.

Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease

Mateos L, Ismail MA, Gil-Bea FJ, Leoni V, Winblad B, Björkhem I, Cedazo-Mínguez A.

J Alzheimers Dis. 2011;24(4):669-79. doi: 10.3233/JAD-2011-101512.

Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study

Kennelly SP, Abdullah L, Paris D, Parish J, Mathura V, Mullan M, Crawford F, Lawlor BA, Kenny RA.

Int J Geriatr Psychiatry. 2011 Oct;26(10):1038-45. doi: 10.1002/gps.2638. Epub 2010 Oct 29.

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ.

Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5819-24. doi: 10.1073/pnas.1017033108. Epub 2011 Mar 18.

The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study

De Reuck J, Deramecourt V, Cordonnier C, Leys D, Maurage CA, Pasquier F.

Eur J Neurol. 2011 Jun;18(6):913-8. doi: 10.1111/j.1468-1331.2010.03329.x. Epub 2011 Jan 18.

Docking of the alkaloid geissospermine into acetylcholinesterase: a natural scaffold targeting the treatment of Alzheimer's disease

Araújo JQ, Lima JA, Pinto Ada C, de Alencastro RB, Albuquerque MG.

J Mol Model. 2011 Jun;17(6):1401-12. doi: 10.1007/s00894-010-0841-2. Epub 2010 Sep 16.

The ability of tolfenamic acid to penetrate the brain: a model for testing the brain disposition of candidate Alzheimer's drugs using multiple platforms

Subaiea GM, Alansi BH, Serra DA, Alwan M, Zawia NH.

Curr Alzheimer Res. 2011 Dec;8(8):860-7. doi: 10.2174/156720511798192691.

Consequences of antipsychotic medications for the dementia patient

Devanand DP, Schultz SK.

Am J Psychiatry. 2011 Aug;168(8):767-9. doi: 10.1176/appi.ajp.2011.11040629.